Cargando…

Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore

Introduction Chronic kidney disease-related mineral and bone disorder (CKD-MBD), characterized by abnormalities in calcium, phosphate, and parathyroid hormone metabolism, with impaired bone turnover and extravascular calcification is a known complication of advanced chronic kidney disease (CKD). Sec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Behram A, Qu, XiaoJie, Hua, Yan, Javaid, Muhammad M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693497/ https://www.ncbi.nlm.nih.gov/pubmed/38050530 http://dx.doi.org/10.7759/cureus.48186

Ejemplares similares

Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”
por: Russo, Domenico, et al.
Publicado: (2019)

Managing hyperparathyroidism in hemodialysis: role of etelcalcetide
por: Eidman, Keith E, et al.
Publicado: (2018)

Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management
por: Habas, Elmukhtar, et al.
Publicado: (2021)

Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients
por: Cunningham, John, et al.
Publicado: (2019)

An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism
por: Block, Geoffrey A., et al.
Publicado: (2019)

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
por: Bushinsky, David A, et al.
Publicado: (2019)

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
por: Bushinsky, David A, et al.
Publicado: (2019)

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
por: Cozzolino, Mario, et al.
Publicado: (2017)

Use of Parathyroid Function Index and Wisconsin Index to Differentiate Primary Hyperparathyroidism From Secondary Hyperparathyroidism: A Case-Control Study
por: Özkan, Murat Bulut, et al.
Publicado: (2022)

Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis
por: Wolf, Myles, et al.
Publicado: (2019)

Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma
por: Win, George M, et al.
Publicado: (2021)

Secondary Hyperparathyroidism Presenting as a Brown Tumor: A Case Report and Review of the Literature
por: Flores, Rui, et al.
Publicado: (2023)

Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis
por: Chen, P, et al.
Publicado: (2016)

A Single- and Multiple-Dose, Multicenter Study of Etelcalcetide in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism
por: Yokoyama, Keitaro, et al.
Publicado: (2017)

Association of Major Depressive Disorder in Hyperparathyroidism: A Systematic Review
por: Desai, Anjali, et al.
Publicado: (2023)

Association Between Primary Hyperparathyroidism and Secondary Diabetes Mellitus: Findings From a Scoping Review
por: Barnett, Maxim J
Publicado: (2023)

Recurrent Primary Hyperparathyroidism in Hyperparathyroid Jaw Tumor Syndrome: A Case Report
por: Kang, James R, et al.
Publicado: (2023)

Lithium-induced Hyperparathyroidism and Hypercalcemia
por: Naramala, Srikanth, et al.
Publicado: (2019)

Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy
por: Friedl, Claudia, et al.
Publicado: (2018)

A Prospective, Randomized Clinical Trial of Etelcalcetide in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism (the DUET Trial)
por: Itano, Yuya, et al.
Publicado: (2020)

A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride
por: Nakamura, Hironori, et al.
Publicado: (2021)

Acute Psychosis Related to Primary Hyperparathyroidism in a Patient With Bipolar Disorder
por: Khan, Zahid, et al.
Publicado: (2023)

Masked Primary Hyperparathyroidism by Empagliflozin Use
por: Awada, Mariam, et al.
Publicado: (2022)

A Rare Manifestation of Unknown Hyperparathyroidism as a Perforated Peptic Ulcer
por: Mlawa, Gideon, et al.
Publicado: (2023)

The Utility of Ultrasound in the Preoperative Localization of Primary Hyperparathyroidism: Insights from Pakistan
por: Fatima, Tehseen, et al.
Publicado: (2020)

Correction: Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”. J. Clin. Med. 2019, 8, 1066
por: Russo, Domenico, et al.
Publicado: (2020)

A Clinical Review of the Psychiatric Sequelae of Primary Hyperparathyroidism
por: Serdenes, Ryan, et al.
Publicado: (2021)

Primary Hyperparathyroidism Causing Psychosis: A Case Report
por: Meng, Aaron Z, et al.
Publicado: (2022)

The Impact of Moderate Hypophosphatemia on the Clinical Management of Primary Hyperparathyroidism
por: Güneş, Elif, et al.
Publicado: (2023)

Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue
por: Esposito, Melisa, et al.
Publicado: (2023)

Gastrointestinal Neuroendocrine Tumor, Colon Adenocarcinoma, and Hyperparathyroidism: An Unorthodox Synchronism
por: Aslam, Hafiz M, et al.
Publicado: (2018)

Case Report of Transient Neonatal Hyperparathyroidism: Medically Free Mother
por: Almidani, Eyad, et al.
Publicado: (2020)

Ectopic Pleural Parathyroid Adenoma Causing Recurrent Primary Hyperparathyroidism
por: Kaur, Jasleen, et al.
Publicado: (2022)

Familial Hyperparathyroidism: A Diagnostic and Treatment Challenge in Saudi Arabia
por: AlNassar, Hind, et al.
Publicado: (2022)

Increased Prevalence of Autoimmune Rheumatologic Diseases in Patients With Primary Hyperparathyroidism
por: Güneş, Elif, et al.
Publicado: (2023)

Concurrent Primary Hyperparathyroidism and Sarcoidosis in a Patient With Severe Hypercalcemia
por: Ayyad, Mohammed, et al.
Publicado: (2023)

Coexistence of a Calcium-Sensing Receptor Mutation and Primary Hyperparathyroidism
por: Russell, Peyton, et al.
Publicado: (2023)

Primary Hyperparathyroidism: To Evaluate Benefit of Ultrasound and Tc99m-SESTAMIBI Scan in Localizing Abnormal Parathyroid Gland Before Surgery, in a Secondary Care Hospital
por: Rehman, Habib U, et al.
Publicado: (2020)

Hip Fracture in a Patient with Primary Hyperparathyroidism: Medical and Surgical Lessons
por: Baig, MN, et al.
Publicado: (2018)

Hypercalcemia due to Co-Occurring Metastatic Breast Cancer and Primary Hyperparathyroidism
por: Khubaib, Mohammad U, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_27useu7075n8oesaug2bn6np4h